Applications of nuclear magnetic resonance spectroscopy in the screening of new psychoactive substances

LUAN Jiaqi; JIA Wei; HUA Zhendong; XU Peng; SU Mengxiang; WANG Youmei; DI Bin

doi:10.11665/j.issn.1000-5048.20180505

Journal of China Pharmaceutical University > 2018 > 49(5): 545-552. > DOI: 10.11665/j.issn.1000-5048.20180505

LUAN Jiaqi, JIA Wei, HUA Zhendong, XU Peng, SU Mengxiang, WANG Youmei, DI Bin. Applications of nuclear magnetic resonance spectroscopy in the screening of new psychoactive substances[J]. Journal of China Pharmaceutical University, 2018, 49(5): 545-552. DOI: 10.11665/j.issn.1000-5048.20180505

Citation:

PDF (1373 KB)

Applications of nuclear magnetic resonance spectroscopy in the screening of new psychoactive substances

LUAN Jiaqi¹,
JIA Wei^2,3,
HUA Zhendong^2,3,
XU Peng^2,3,
SU Mengxiang^1,3,
WANG Youmei^2,3,
DI Bin^1,3

More Information

Graphical Abstract

Abstract

Abstract

GC-MS and LC-MS are the main techniques used for the structural identification of new psychoactive substances at present. However, they are hard to give accurate structure information because of the hardly available corresponding reference standards and the quickly changing status of these compounds. This leads tremendous obstacle on the rapid identification of new psychoactive substances. Nuclear magnetic resonance spectroscopy is one of the most effective methods for structures identification. Therefore, NMR is especially suitable for the analysis and identification of new psychoactive substances even with rapid structural changes. This article summarizes the NMR applications for the structural analysis of new psychoactive substances including synthetic cannabinoids, synthetic cathinones, piperazines, phenethylamines, ketamine & phencyclidine-type substances, and fentanyls. It is found that the NMR signals of the main frame structure of each kind of the new psychoactive substances are basically the same. Hence, these frame structure NMR signals can provide scientific evidence for the rapid identification of new psychoactive substances. This article also look ahead the prospect for the application of LC-NMR and DOSY in new psychoactive substances, which provides new ideas for the screening of new psychoactive substances.

FullText(HTML)

References (49)

References

[1]	United Nations Office on Drugs and Crime.The challenge of new psychoactive substances(a report from the global SMART programme)[R].Austria:UNODC,2013.
[2]	You Y,Deng Y,Zhao M.Third generation drugs - new psychoactive substance(NPS)development trend evaluation,regulatory bottlenecks and coping strategies[J].J Sichuan Police College(四川警察学院学报),2017,29(1):97-102.
[3]	Chang Y,Hu YP,Zhao Y,et al.Review of new piperazine-type psychoactive substances[J].Forensic Sci Technol(刑事技术),2016,41(4):317-321.
[4]	Qian ZH,Qiao HW,Hua ZD.Determination of 8 synthetic cannabinoids by gas chromatography-mass spectrometry[J].Chin J Forensic Med(中国法医学杂志),2015,30(1):1-4.
[5]	Hua ZD,Jia W,Li K.Study on mass spectrometry characteristics of naphthoyl hydrazide synthetic cannabinoids[J].Police Technol(警察技术),2013(4):15-18.
[6]	Liu Y,Wang CH,Xu JZ,et al.Determination of drug abuse in hair(1)Morphine[J].Forensic Sci Technol(刑事技术),1996(2):1-4.
[7]	Liu Y,Wang CH,Xu JZ,et al.Determination of drug abuse in hair(2)Heroin[J].Forensic Sci Technol(刑事技术),1996(3):1-4.
[8]	Wang CH,Xu JZ,Gu CH,et al.Determination of drug abuse in hair(3)Tetrahydrocannabinol[J].J Chin Mass Spectrom Soc(质谱学报),1997,18(3):7-12.
[9]	Liu CM,Hua ZD,Bai YP.UPLC-MS/MS and principal component analysis to distinguish heroin origin[J].Chin J Analysis Lab(分析试验室),2013,32(8):35-39.
[10]	Zhang TT,Liu CM,Qian ZH,et al.Identification of novel synthetic cannabinoids[J].Police Technol(警察技术),2017(6):87-90.
[11]	Li J,Hua ZD,Wang YM.Analysis of metabolites and metabolic pathway of 5F-AMB in vitro using UPLC-HR-MS[J].Acta Pharm Sin(药学学报),2017,52(11):1743-1747.
[12]	Qian ZH,Hua ZD,Jia W.Study on the mass spectrometry characteristics of the 8th generation carbazole amide synthetic cannabinoids[C]//China Chemical Society National Mass Spectral Analysis Academic Report Meeting.2015:121.
[13]	Li P,Zhao Y,Zhao YB,et al.NMR and qNMR for drug analysis[J].Forensic Sci Technol(刑事技术),2017,42(4):312-323.
[14]	Penn HJ,Langman LJ,Unold D,et al.Detection of synthetic cannabinoids in herbal incense products[J].Clin Biochem,2011,44(13):1163-1165.
[15]	Seely KA,Lapoint J,Moran JH,et al.Spice drugs are more than harmless herbal blends:a review of the pharmacology and toxicology of synthetic cannabinoids[J].Prog Neuro-Psychoph,2012,39(2):234.
[16]	Mills B,Yepes A,Nugent K.Synthetic cannabinoids[J].Am J Med Sci,2015,350(1):59-62.
[17]	Castellanos D,Singh S,Thornton G,et al.Synthetic cannabinoid use:a case series of adolescents[J].J Adolescent Health,2011,49(4):347-349.
[18]	European monitoring centre for drugs and drug addiction.European drug report trends and developments[R].Turkey and Norway:EMCDDA,2016.
[19]	Shevyrin V, Melkozerov V, Nevero A, et al. Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group[J].Anal Bioanal Chem,2015,407(21):6301-6315.
[20]	Amato J,Iaccarino N,Pagano B.NMR assignment of N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide seized as herbal incense for the first time in Italy[J].Eur J Org Chem,2014,1(4):4577-4584.
[21]	Dunne SJ,Rosengren-Holmberg JP.Quantification of synthetic cannabinoids in herbal smoking blends using NMR[J].Drug Test Anal,2017,9(5):734-743.
[22]	Spiller HA,Ryan ML,Weston RG,et al.Clinical experience with and analytical confirmation of “bath salts” and “legal highs”(synthetic cathinones)in the United States[J].Clin Toxicol,2011,49(6):499-505.
[23]	Schifano F,Albanese A,Fergus S,et al.Mephedrone(4-methylmethcathinone;‘meow meow’):chemical,pharmacological and clinical issues[J].Psychopharmacology,2011,214(3):593-602.
[24]	Glennon RA,Yousif M,Naiman N,et al.Methcathinone:a new and potent amphetamine-like agent[J].Pharmacol Biochem Behav,1987,26(3):547-551.
[25]	Qian ZH,Xu P,Liu KL.New drug of designer cathinones ‘Bath Salts’[J].Chin J Drug Abuse Prev Treat(中国药物滥用防治杂志),2013,19(1):42-44.
[26]	Westphal F,Junge T,Rosner P,et al.Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone:a designer drug with alpha-pyrrolidinophenone structure[J].Forensic Sci Int,2009,190(1/2/3):1-8.
[27]	Westphal F,Junge T,Klein B,et al.Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone:a new designer drug with pyrrolidinophenone structure[J].Forensic Sci Int,2011,209(1):126-132.
[28]	Huang X,Wang WX,Xu P,et al.Identification of N-methyl-3,4-methylenedioxycathinone from the unknown white crystalline substance[J].Chin J Forensic Med(中国法医学杂志),2012,27(6):474-476.
[29]	Mohammed M,Darshini D,Sindhu R,et al.Designer drug-Trifluoromethylphenylpiperazine derivatives(TFMPP)-A future potential peril towards modern society[J].Med Res Arch,2017,5(8):1-27.
[30]	Bossong MG,Brunt TM,Van Dijk JP,et al.mCPP:an undesired addition to the ecstasy market[J].J Psychopharmacology,2010,24(9):1395-1401.
[31]	Subashini K,Periandy S.Spectroscopic(FT-IR,FT-Raman,UV,NMR,NLO)investigation and molecular docking study of 1-(4-methylbenzyl)piperazine[J].J Mol Struct,2016,1117:240-256.
[32]	Qu LB,Liang RL,Chen SX.The quantum chemistry investigation of 1-benzyl-piperazine derivatives and its correlation with ¹³C-NMR chemical shifts[J].J Zhengzhou Univ Light Ind(郑州轻工业学院学报),2006,21(2):6-9.
[33]	Romão W,Lalli PM,Franco MF,et al.Chemical profile of meta-chlorophenylpiperazine(m-CPP)in ecstasy tablets by easy ambient sonic-spray ionization,X-ray fluorescence,ion mobility mass spectrometry and NMR[J].Anal Bioanal Chem,2011,400(9):3053-3064.
[34]	Rong R,Shan X,Zhang SG,et al.Incorporation of new psychoactive substances in forensic toxicology teaching[J].Edu Teach Forum(教育教学论坛),2017(38):181-184.
[35]	Jia DM,Guo S,Yu ZJ,et al.Designer drugs:overview,pharmacology and clinical issues[J].Chin J Drug Abuse Prev Treat(中国药物滥用防治杂志),2018,24(1):57-62.
[36]	Zuba D,Sekua K.Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs[J].Drug Test Anal,2013,5(8):634-645.
[37]	Giroud C,Augsburger ML,Mangin P,et al.2C-B:a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market[J].J Anal Toxicol,1998,22(5):345-354.
[38]	Liu ZM.Ketamine abuse and its consequences for public health and social problems[J].Chin J Drug Depend(中国药物依赖性杂志),2016,25(1):2-10.
[39]	Peng W,Yue YC,He CJ,et al.Comparative analysis of clinical mental symptoms of mental disorders caused by amphetamine-type psychotropic substances,ketamine and their mixed abuse[J].Chin J Histochem Cytochem(中国组织化学与细胞化学杂志),2017,10:160.
[40]	Frison G,Zamengo L,Zancanaro F,et al.Characterization of the designer drug deschloroketamine(2-methylamino-2-phenylcyclohexanone)by gas chromatography/mass spectrometry,liquid chromatography/high-resolution mass spectrometry,multistage mass spectrometry,and nuclear magnetic resonance[J].Rapid Commun Mass Spectrom,2016,30(1):151-160.
[41]	Han JH,Fan JY.Four kinds of fentanyl compounds such as caffentani are administered in China[J].Chin J Drug Depend(中国药物依赖性杂志),2017,26(4):269.
[42]	Liu ZM.Abuse and control of fentanyl and its derivatives:hazards and challenges[J].Chin J Drug Depend(中国药物依赖性杂志),2017,26(4):274-276.
[43]	Skulska A,KaLA M,Parczewski A.Fentanyl and its analogues in the forensic laboratory.Medical and analytical problems[J].Z Zagadnien Nauk Sadowych,2004,59(9):127-142.
[44]	Yang YL,Zhu XW,Ren GT,et al.The anesthetic effect and toxicity of some substituted fentanyl compounds in rabbits[J].J China Pharm Univ(中国药科大学学报),1994,25(1):1-2.
[45]	Liu C,Li T,Han Y,et al.The identification and analytical characterization of 2,2′-difluorofentanyl[J].Drug Test Anal,2017:1-7.
[46]	Breindahl T,Kimergård A,Andreasen MF,et al.Identification of a new psychoactive substance in seized material:the synthetic opioid N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide(acrylfentanyl)[J].Drug Test Anal,2016,9(3):415-422.
[47]	Cui KJ,Wang P,Xu ZB,et al.A new method for synthesizing carfentanil[J].Transactions Beijing Institute Technol(北京理工大学学报),2012,32(10):1082-1085.
[48]	Deng ZW,Li J,Xu MF,et al.Application of NMR techniques in pharmaceutical assay[J].J Instr Anal(分析测试学报),2012,31(9):1081-1088.
[49]	Balayssac S,Retailleau E,Bertrand G,et al.Characterization of heroin samples by ¹H-NMR and 2D-DOSY ¹H-NMR[J].Forensic Sci Int,2014,234(1):29-38.

[1]	SU Haiying, WANG Yukun, LI Weisong, ZHOU Jianping, CHENG Hao. Advances in anti-Alzheimer’s disease nano drug delivery system based on pathogenic mechanism of ferroptosis[J]. Journal of China Pharmaceutical University, 2024, 55(5): 613-623. DOI: 10.11665/j.issn.1000-5048.2024040702
[2]	CHANG Yuan, MAGETA Mageta Samwel, LI Nibowen, TANG Yingqi, LI Huangjuan, QIAN Chenggen. Research advances in modulating microglia for intervening in Alzheimer’s disease[J]. Journal of China Pharmaceutical University, 2024, 55(5): 603-612. DOI: 10.11665/j.issn.1000-5048.2024030201
[3]	LAN Aili, LIU Gang, WU Chaoran, LIAO Hong. Research progress of integrated stress response in central nervous system diseases[J]. Journal of China Pharmaceutical University, 2024, 55(2): 194-201. DOI: 10.11665/j.issn.1000-5048.2023112302
[4]	ZHAO Mengqi, LIAO Hong. Researches progress of the relationship between neuro-inflammation and cognitive function[J]. Journal of China Pharmaceutical University, 2019, 50(4): 497-504. DOI: 10.11665/j.issn.1000-5048.20190416
[5]	CHEN Suting, CHEN Song, GAO Xiangdong. Construction, expression, purification and neuroprotective activity of TAT-FGF21 fusion protein[J]. Journal of China Pharmaceutical University, 2018, 49(4): 496-501. DOI: 10.11665/j.issn.1000-5048.20180417
[6]	YU Haiyang, CHEN Song, XU Zheng, GAO Xiangdong, YAO Wenbing. Protective effect of fibroin peptides on Aβ_25-35-induced injury in SH-SY5Y cells and its mechanism[J]. Journal of China Pharmaceutical University, 2017, 48(5): 609-613. DOI: 10.11665/j.issn.1000-5048.20170517
[7]	YAN Ruizuo, GUO Baojian, YU Pei, ZHANG Zaijun. Effect of rasagiline on neuroprotection and behavior improvement in MPTP-induced acute mouse model of Parkinson′s disease[J]. Journal of China Pharmaceutical University, 2016, 47(5): 603-608. DOI: 10.11665/j.issn.1000-5048.20160517
[8]	NI Jie, LIU Gaoxiang, LIAO Hong. Expression of p75 neurotrophin receptor and its role in drug development[J]. Journal of China Pharmaceutical University, 2015, 46(6): 751-756. DOI: 10.11665/j.issn.1000-5048.20150620
[9]	CHEN Mengfei, FANG Lei, CHEN Li. Design, synthesis and anti-Alzheimer′s disease activity of 5-akylaminomethyl substituted carbazole derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(6): 647-652. DOI: 10.11665/j.issn.1000-5048.20150602
[10]	SHEN Kai, KOU Junping, YU Boyang. Research advances in the mechanisms of active components in Chinese materia medica against oxidative stress-induced neuronal apoptosis[J]. Journal of China Pharmaceutical University, 2015, 46(5): 532-540. DOI: 10.11665/j.issn.1000-5048.20150503

Cited By

Cited by

Periodical cited type(6)

1.	段盼盼，赵丽娟，吴姿，杨子妮，王燕清. 直接进样气相色谱法用于助悬剂中乙二醇二甘醇和三甘醇残留量测定方法研究. 实用医技杂志. 2024(04): 241-244 .
2.	孔祥祥，李建兵，陈东，孙晨磊，王婷，孙云，臧金秋，宋蕾，梁野. 气相色谱法测定聚乙二醇200中乙二醇、二甘醇、三甘醇和四甘醇含量. 质量安全与检验检测. 2024(03): 6-9 .
3.	黄丽梅，曹玉，戴震，仝立卿，张珂. GC法测定对乙酰氨基酚口服液体制剂辅料中乙二醇及二甘醇残留量. 云南化工. 2024(08): 124-127 .
4.	杨军林，陈明学，田栋伟，尹艳艳，张二康，尤小龙，张健，程平言. GC-MS/MS法直接测定酱香型白酒中二乙二醇的含量. 食品科技. 2022(06): 303-309 .
5.	郜淑晓，祝颂，赵恂，袁耀佐，宋敏，杭太俊，陆宇婷. 聚氧乙烯中乙二醇和二甘醇残留的HPLC和GC测定法比较研究. 药物分析杂志. 2020(10): 1820-1827 .
6.	田嘉铭，于小红，王银月，王旭，王治宝，王金，卢金铭. 气相色谱法测定糖平煎复方中苍术酮含量. 神经药理学报. 2020(05): 14-17 .

Other cited types(1)

Get Citation

PDF

XML

Article views (908) PDF downloads (1392) Cited by(7)

Turn off MathJax

Article Contents

Abstract

References

Applications of nuclear magnetic resonance spectroscopy in the screening of new psychoactive substances

Abstract

References

Related Articles

Cited by

Periodical cited type(6)

Other cited types(1)

Catalog

Applications of nuclear magnetic resonance spectroscopy in the screening of new psychoactive substances

Abstract

References

Related Articles

Cited by

Periodical cited type(6)

Other cited types(1)

Catalog

Export File

Citation

Format

Content